Tetsuya Ishikawa
Tetsuya Ishikawa publishes mostly in Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging, on topics such as Coronary Interventions and Diagnostics, Acute Myocardial Infarction Research and Cardiac Imaging and Diagnostics.
- World rank
- #3,791,489 of 7,710,434 ranked researchers
- Rank in Japan
- #97,911 of 383,136
- Works
- 216
- Citations
- 2.9k
- Citations per work
- 13.2
What does Tetsuya Ishikawa research?
Tetsuya Ishikawa's work is mostly in Medicine (70%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences15069.5%
- Medicine15069.5%
- Everything else6630.5%
- 1Cardiology and Cardiovascular Medicine30% of their works
- 2Surgery21% of their works
- 3Radiology, Nuclear Medicine and Imaging7% of their works
- 4Pulmonary and Respiratory Medicine5% of their works
- 5Epidemiology3% of their works
- 6Endocrinology, Diabetes and Metabolism3% of their works
Research topics
- Coronary Interventions and Diagnostics
- Acute Myocardial Infarction Research
- Cardiac Imaging and Diagnostics
- Antiplatelet Therapy and Cardiovascular Diseases
- Atrial Fibrillation Management and Outcomes
- Cardiac Valve Diseases and Treatments
- Cardiac Arrhythmias and Treatments
- Cardiovascular Function and Risk Factors
Which keywords describe Tetsuya Ishikawa's research?
The keywords of their largest research topics: Percutaneous Coronary Intervention, Coronary Stents, Myocardial Revascularization, Myocardial Infarction, Guidelines, Catheter Ablation, Acute Coronary Syndromes and ST-Segment Elevation.
- Echocardiography
- Ventricular Tachycardia
- Transcatheter Aortic-Valve Replacement
- Atrial Fibrillation
- Clopidogrel
- Coronary Artery Disease
- ST-Segment Elevation
- Catheter Ablation
- Myocardial Infarction
- Coronary Stents
- Percutaneous Coronary Intervention
- Myocardial Revascularization
- Guidelines
- Acute Coronary Syndromes
- Cardiac Imaging
- Aspirin
- Anticoagulant Therapy
- Surgical Aortic-Valve Replacement
- Arrhythmias
- Chamber Quantification
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Percutaneous Coronary Intervention1002 topics
- Coronary Stents771 topic
- Myocardial Revascularization771 topic
- Myocardial Infarction612 topics
- Guidelines522 topics
- Catheter Ablation342 topics
- Acute Coronary Syndromes311 topic
- ST-Segment Elevation311 topic
- Cardiac Imaging301 topic
- Coronary Artery Disease301 topic
- Aspirin231 topic
- Clopidogrel231 topic
- Anticoagulant Therapy211 topic
- Atrial Fibrillation211 topic
- Surgical Aortic-Valve Replacement201 topic
- Transcatheter Aortic-Valve Replacement201 topic
- Arrhythmias131 topic
- Ventricular Tachycardia131 topic
- Chamber Quantification121 topic
- Echocardiography121 topic
Where does Tetsuya Ishikawa work?
Tetsuya Ishikawa's main affiliation in the publication record is Social Insurance Saitama Chuo Hospital, Japan.
How many publications and citations does Tetsuya Ishikawa have?
OpenAlex counts 216 works and 2,857 citations for Tetsuya Ishikawa, an h-index of 27, ranking #3,791,489 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Tetsuya Ishikawa
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Tetsuya Ishikawa. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.